Teratological Consequences of Nitric Oxide Synthesis Inhibition

Author(s): Gian Mario Tiboni, Ettore Clementini

Journal Name: Current Pharmaceutical Design

Volume 10 , Issue 22 , 2004

Become EABM
Become Reviewer
Call for Editor

Abstract:

Nitric oxide (NO) is generated by a family of NO synthase (NOS) enzymes, including endothelial (eNOS), inducible (iNOS) and neuronal (nNOS). NO is an important bioregulator of a wide variety of physiological processes. Recent experimental evidence indicates that inhibition of NO synthesis can lead to teratogenesis. The current review focuses on this aspect of NOS. Exposure of pregnant rodents to non-selective NOS inhibitors, such as NG-nitro- Larginine- methyl ester (L-NAME) and NG-nitro-L-arginine (L -NNA), has been linked to limb reduction defects. The teratogenic phenotype, characterized by hemorrhage and transverse terminal tissue destruction, has been regarded to be compatible with a vascular origin. The critical time for teratogenic response was traced to advanced stages of gestation. Similar limb reduction defects have been described in mice deficient in eNOS, but not in other NOS isoforms. Several observations have led to the proposal that hypoxia and possible consequential generation of reactive oxygen species are involved in the causation of NOS inhibitors induced limb defects.

Keywords: nitric oxide, nitric oxide synthase, nitric oxide synthase inhibitors, teratogenesis, limb defects, cardiovascular defects, rat, mouse

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 10
ISSUE: 22
Year: 2004
Page: [2759 - 2767]
Pages: 9
DOI: 10.2174/1381612043383665
Price: $65

Article Metrics

PDF: 6